Group items tagged

Tynor Exercising Ball Exercising ball is an excellent physiotherapy device to provide a pleasurable exercise plan for the hand, wrist, forearm and the fingers Safe and inert. High patient compliance. Excellent resilience for a long functional life . Compatible in thermal/hydrotherapy. Tynor Exercising Ball Features Ergonomic design and materials Two resistances available- Ortho (hard) & Neuro (soft) Compatible for thermal/hydrotherapy Flexible and pleasurable exercise schedules can be planned Better compliance Inert PU material, safe to use Excellent resilience, offers longer life. Tynor Exercising Ball Measurements Sizes Available: OR / NR

The company is focused on protecting the brain from emboli to reduce the risk of brain infarcts during TAVR, surgical valve replacement, atrial fibrillation ablation, and other cardiovascular procedures. The TriGuard™ and TriGUARD 3™ product pipelines are designed to help interventional cardiologists and electrophysiologists to preserve brain reserve in patients undergoing these procedures.

We invite you to explore and discuss with world-renown physicians the importance of complete cerebral embolic protection with TAVR. Please join us for the Keystone Heart Lunch Symposium during TCT 2018where we will share current research on cerebral embolic debris during TAVR, progress of the US REFLECT trial using TriGUARD 3™, early US experience and commentary with TriGUARD 3™.

The cardiac procedures like heart bypass surgery or open heart surgery may lead to serious outcomes for the brain and nervous system. Researches have indicated that owing to the serious threat to the brain led by heart surgery, several preventive measures have been taken by doctors, including the use of cerebral embolic protection (CEP) devices.

There is a lack of an objective point-of-injury (POI) or point-of-care (POC) test. TBI testing today is symptomatic diagnosis, which has a high error rate..

Biolumo's flagship product is a fast, point-of-care antibiotics selection device for general practitioners and clinics. The company is offering diagnostic..

The medical diagnostics industry is advancing at a fast-paced. The new innovations come with a promise to enhance the accuracy of detecting diseases...

Apple has joined forces with Eli Lilly and Evidation Health on a new feasibility study to detect evidence of brain decline with data from personal digital devices. The research has revealed that these devices may help in the identification of mild cognitive impairment (MCI) and Alzheimer's disease dementia.

The global pharmacy automation devices market size was valued at USD 4.8 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 9.3% from 2021 to 2028

The global medical device outsourcing market size was valued at USD 99.9 billion in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 11.2% over the forecast period.

The global capnography devices market size was valued at USD 510.7 million in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 9.7% from 2021 to 2028.

The global craniomaxillofacial devices market size was valued at USD 1.6 billion in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 9.0% over the forecast period.

The global traumatic brain injury assessment and management devices market size is anticipated to reach USD 5.5 billion by 2028

The global blood pressure monitoring devices market size is expected to expand at a CAGR of 11.2% from 2021 to 2028.

The global neurothrombectomy devices market size was valued at USD 634.2 million in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 6.5% from 2021 to 2028.

The global catheter stabilization devices market size is expected to reach USD 1.83 billion by 2025, according to a new report

The global medical device outsourcing market size is expected to reach USD 227.1 billion by 2028 registering a CAGR of 11.2%, according to a new report

Novo Nordisk has launched PenCycle, a recycling initiative for pre-filled injection pens, designed to address the challenge of recycling injection pen devices. A first-of-its-kind scheme in the UK, covering FlexPen® and FlexTouch® used to dispense insulin and other medications, will have community pharmacies playing a key role. Users can return their devices to local participating community pharmacies or through pre-paid Royal Mail boxes or use an 'at home' collection pilot service for growth hormone pens. The pens will then be returned to Denmark where the plastic will be recycled into a range of items, such as chairs and lamps, the Danish multinational pharmaceutical company said.